2018-04-27
Corrigendum: Vedolizumab in paediatric inflammatory Bowel Disease: A retrospective multi-centre experience from the paediatric IBD Porto Group of ESPGHAN [Journal of Crohn's and Colitis, 630 (2018)]
Publication
Publication
doi:10.1093/ecco-jcc/jjx172
Journal of Crohn's and Colitis , Volume 12 - Issue 5 p. 630- 630
In the original article, author Carsten Posovszky's surname was incorrectly spelt. This has now been corrected.
Additional Metadata | |
---|---|
dx.doi.org/10.1093/ecco-jcc/jjx172, hdl.handle.net/1765/106312 | |
Journal of Crohn's and Colitis | |
Organisation | Erasmus MC: University Medical Center Rotterdam |
Ledder, O. (Oren), Assa, A. (Amit), Levine, A, Escher, J.C, de Ridder, L, Ruemmele, F.M, … Turner, D. (2018). Corrigendum: Vedolizumab in paediatric inflammatory Bowel Disease: A retrospective multi-centre experience from the paediatric IBD Porto Group of ESPGHAN [Journal of Crohn's and Colitis, 630 (2018)]. Journal of Crohn's and Colitis, 12(5), 630–630. doi:10.1093/ecco-jcc/jjx172
|